Liver disease and drug therapy.
D000654:Amobarbital / Q000378:metabolism; D001379:Azathioprine / Q000378:metabolism; D006207:Half-Life; D006801:Humans; D008012:Lidocaine / Q000378:metabolism; D008103:Liver Cirrhosis / Q000378:metabolism; D008107:Liver Diseases / Q000201:enzymology / Q000378:metabolism*; D008657:Metabolic Clearance Rate; D009560:Niridazole / Q000378:metabolism; D010424:Pentobarbital / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010653:Phenylbutazone / Q000378:metabolism; D011241:Prednisone / Q000378:metabolism; D012552:Schistosomiasis / Q000378:metabolism; D013462:Sulfur Radioisotopes; D014044:Tolbutamide / Q000378:metabolism
D004364:Pharmaceutical Preparations; D013462:Sulfur Radioisotopes; D014044:Tolbutamide; D008012:Lidocaine; D010653:Phenylbutazone; D000654:Amobarbital; D010424:Pentobarbital; D001379:Azathioprine; D009560:Niridazole; D011241:Prednisone